Polycystic ovary syndrome (PCOS) which was recently renamed polyendocrine metabolic ovarian syndrome (PMOS) affects up to 5 million women in the U.S., yet diagnoses are often missed or delayed, and managing the condition remains inconsistent
Off-label use of drugs, after all, is hardly uncommon
Unlike orlistat, which blocks fat absorption, or phentermine, which is a stimulant-based appetite suppressant, GLP-1 receptor agonists address hunger and satiety at the hormonal level, targeting a fundamental aspect of overeating
Physiologia Plantarum
Exendin-4 improves thermogenic capacity by regulating fat metabolism on brown adipose tissue in mice with diet-induced obesity
Database, functions, workflow, sync, search, file storage, and more